Skip to main content

Medtronic plc ownership: holders and insider trading

  • MDT · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$102.86+1.85%Close 13 Nov 2026 · Market value $132.0B · Next results 24 Nov 2026

As filed, its directors and officers own 0.3% of the shares (proxy statement, 5 Aug 2026); 2,107 institutional managers reported holding 86.3% at 30 Jun 2026. Over the last twelve months, insiders sold $14.67M of shares on the open market, $6.01M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
The Vanguard GroupHolder117M9.12%Proxy statement5 Aug 2026
BlackRock, Inc.Holder112M8.72%Proxy statement5 Aug 2026
Vanguard Capital ManagementHolder96.4M7.51%Schedule 13G31 Mar 2026
State StreetInstitution66.1M5.2%Schedule 13G30 Sep 2026
Geode Capital ManagementInstitution30.2M2.36%*Form 13F30 Jun 2026
JPMorgan ChaseInstitution27.8M2.17%*Form 13F30 Jun 2026
First Eagle Investment Management, LLCInstitution27.6M2.15%*Form 13F30 Jun 2026
Capital GroupInstitution21.6M1.69%*Form 13F30 Jun 2026
Bank of AmericaInstitution21.3M1.67%*Form 13F30 Jun 2026
Massachusetts Financial Services CoInstitution19.9M1.55%*Form 13F30 Jun 2026
Morgan StanleyInstitution19.4M1.52%*Form 13F30 Jun 2026
Deutsche BankInstitution18.4M1.44%*Form 13F30 Jun 2026
InvescoInstitution17.9M1.40%*Form 13F30 Jun 2026
Franklin TempletonInstitution17.6M1.37%*Form 13F30 Jun 2026
Norges BankInstitution16.6M1.29%*Form 13F30 Jun 2026
Royal Bank of CanadaInstitution16.0M1.25%*Form 13F30 Jun 2026
BNYInstitution14.7M1.15%*Form 13F30 Jun 2026
Arrowstreet Capital, Limited PartnershipInstitution12.9M1.01%*Form 13F30 Jun 2026
Northern TrustInstitution11.6M0.91%*Form 13F30 Jun 2026
AmeripriseInstitution11.6M0.90%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Marinaro Michael · President2 Nov 2026Grant or award+6.5K——
Marinaro Michael · EVP, Pres MedSurg and Americas15 Oct 2026Open-market sale (10b5-1 plan)−10.4K$96.00$1.00M
Martha Geoffrey · Chairman and CEO · Director15 Oct 2026Open-market sale (10b5-1 plan)−50.0K$95.00$4.75M
KIIL HARRY SKIP · EVP & President Cardiovascular16 Sep 2026Open-market sale−1.5K$93.65$138.9K
Marinaro Michael · EVP, Pres MedSurg and Americas20 Aug 2026Shares withheld for tax−1.1K$92.30$100.1K
Thompson Kweli · EVP & President, Neuroscience3 Aug 2026Grant or award+6.9K——
Blomquist Denise L. · Chief Accounting Officer3 Aug 2026Grant or award+2.3K——
Pieton Thierry · EVP & Chief Financial Officer3 Aug 2026Grant or award+11.5K——
Walter Matthew R. · SVP, Chief HR Officer3 Aug 2026Grant or award+5.8K——
Marinaro Michael · EVP, Pres MedSurg and Americas3 Aug 2026Grant or award+46.1K——
Marinaro Michael · EVP, Pres MedSurg and Americas3 Aug 2026Grant or award+11.0K——
Quinn Michelle · EVP, GC and Secretary3 Aug 2026Grant or award+6.3K——
KIIL HARRY SKIP · EVP & President Cardiovascular3 Aug 2026Grant or award+9.2K——
Martha Geoffrey · Chairman and CEO · Director3 Aug 2026Grant or award+41.5K——
Thompson Kweli · EVP & President, Neuroscience31 Jul 2026Shares withheld for tax−1.7K$85.39$148.5K
Blomquist Denise L. · Chief Accounting Officer31 Jul 2026Shares withheld for tax−212$85.39$18.10K
Walter Matthew R. · SVP, Chief HR Officer31 Jul 2026Shares withheld for tax−1.7K$85.39$143.0K
Marinaro Michael · EVP, Pres MedSurg and Americas31 Jul 2026Shares withheld for tax−3.4K$85.39$286.6K
KIIL HARRY SKIP · EVP & President Cardiovascular31 Jul 2026Shares withheld for tax−3.1K$85.39$262.5K
Martha Geoffrey · Chairman and CEO · Director31 Jul 2026Shares withheld for tax−15.8K$85.39$1.35M
Quinn Michelle · EVP, GC and Secretary28 Jul 2026Shares withheld for tax−2.1K$86.88$179.8K
Walter Matthew R. · SVP, Chief HR Officer8 Jul 2026Open-market sale (10b5-1 plan)−3.1K$83.15$257.9K
KIIL HARRY SKIP · EVP & President Cardiovascular8 Jun 2026Open-market sale−228$80.45$18.34K
KIIL HARRY SKIP · EVP & President Cardiovascular8 Jun 2026Open-market sale−4.0K$80.44$318.6K
Blomquist Denise L. · Chief Accounting Officer5 Jun 2026Shares withheld for tax−237$83.32$19.75K

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

MDT in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.